Patents
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
03/2011
03/17/2011CA2773982A1 Methods for treating irritable bowel syndrome (ibs)
03/17/2011CA2773590A1 8-oxodihydropurine derivative
03/17/2011CA2772750A1 Antacid and laxative tablet
03/16/2011EP2295576A1 BMP-12, BMP-13 and tendon-inducing compositions thereof
03/16/2011EP2295456A1 Albumin fusion proteins
03/16/2011EP2295413A1 Indazole compounds useful as protein kinase inhibitors
03/16/2011EP2295412A1 Indazole compounds useful as protein kinase inhibitors
03/16/2011EP2295072A1 Use of ARC for inhibiting cell death during liver failure
03/16/2011EP2295064A1 Monoclonal antibody therapy for pancreas cancer
03/16/2011EP2295063A2 Compositions and the use thereof the treatment of mitochondrial diseases
03/16/2011EP2295060A2 Stabilization of hypoxia inducible factor (HIF) alpha
03/16/2011EP2295059A2 Stabilization of hypoxia inducible factor (HIF) alpha
03/16/2011EP2295055A2 (+)-2-[1-(3-Ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione: Methods of using and compositions thereof
03/16/2011EP2294917A1 Transgenic animals expressing antibodies specific for genes of interest and uses thereof
03/16/2011EP2294012A1 Methods of treating bowel disease by administering a bowel cleanser and an antibiotic
03/16/2011EP2293802A2 Lactose compositions with decreased lactose content
03/16/2011EP2293799A1 Sialic acid to support salivation
03/16/2011EP2293795A1 Pharmaceutical combination
03/16/2011EP2293794A1 Methods of treating mammals with eustachian tube dysfunctions
03/16/2011EP2293677A1 Nutritional composition for infants delivered via caesarean section
03/16/2011EP1448535B1 Benzamide and heteroarylamide as p2x7 receptor antagonists
03/16/2011EP1104281B1 Incorporation of exogenous lactic bacteria into the oral microflora
03/16/2011CN1939324B Medical usage of periplocin A and E
03/16/2011CN1686145B Doxycycline oral cavity adhesion tablet
03/16/2011CN101985471A Folate-IgG conjugate as well as preparation method and application thereof
03/16/2011CN101985028A Chinese medicinal composition for treating gastritis
03/16/2011CN101985027A Chinese herbal medicine for treating liver cirrhosis
03/16/2011CN101985026A Pure Chinese medicinal preparation for rapidly treating halitosis
03/16/2011CN101985025A Red wine for eliminating stomachache
03/16/2011CN101985023A Cream capable of rapidly eliminating lumps
03/16/2011CN101985022A Chinese medicinal composition for treating damp heat enteritis
03/16/2011CN101985017A Chinese medicinal herb for treating appendicitis
03/16/2011CN101985016A Powder for treating gastritis
03/16/2011CN101985015A Yang tonifying health-care tea
03/16/2011CN101985004A Kidney tonifying and stomach reinforcing wine
03/16/2011CN101984994A Medicament for improving human intestinal flora balance and preparation method thereof
03/16/2011CN101984990A Traditional Chinese medicinal composition for treating postpartum frequent urine
03/16/2011CN101984989A Gastrointestinal harmonizing oral liquid for treating gastrointestinal diseases
03/16/2011CN101984976A Compositions for veterinary and medical applications
03/16/2011CN101984957A Method for preparing valnemulin salt premix
03/16/2011CN101703729B Chinese medicament for treating gastropathy
03/16/2011CN101575335B Dehydrogenated silibinin substituted by meta-chlorobenzene formoxyl, preparation method and pharmaceutical applications thereof
03/16/2011CN101530436B Method of effectively extracting ganoderma triterpenoids and ganoderan from mythic fungus germ entity
03/16/2011CN101485754B Medicament for treating gastropathy and preparation method
03/16/2011CN101444603B Pharmaceutical composition for slimming and preparation method thereof
03/16/2011CN101439169B Chinese medicinal composition for treating stomach-ache
03/16/2011CN101401911B Traditional Chinese medicine decoction for treating gastric, duodenal ulcer
03/16/2011CN101357228B Preparation method of hepatitis b human immunoglobulin for intravenous injection
03/16/2011CN101306097B Zengkangning tablets quality control method
03/16/2011CN101249231B Medicine composition for treating lithiasis and preparation thereof
03/16/2011CN101214252B Antiviral antibacterial medicinal composition and preparation thereof
03/16/2011CN101209339B Wax candle with incense treating function and preparation method thereof
03/16/2011CN101138606B Chinese medicinal herb for treating dyspepsodynia
03/16/2011CN101129470B Method of preparing the tablet for hepatitis disease
03/16/2011CN101010067B Modafinil oral lyophilizate
03/15/2011US7906659 Carbocyclic and oxacarbocyclic fumaric acid oligomers
03/15/2011US7906650 Caspase inhibitors and uses thereof
03/15/2011US7906644 2,4-pyrimidinediamine compounds and their uses
03/15/2011US7906141 Sustained-release, oral pharmaceutical forms of formulation
03/15/2011US7905724 Methods and systems for concurrent tooth repositioning and substance delivery
03/15/2011CA2514114C Amino alcohol derivatives, pharmaceutical compositions containing the same, and use thereof
03/15/2011CA2480708C Method and dietary composition for improving fat digestibility
03/15/2011CA2431160C Anilinopyrimidine derivatives as ikk inhibitors and compositions and methods related thereto
03/15/2011CA2426921C Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
03/15/2011CA2412776C Compositions controlling release ph range and/or speed
03/15/2011CA2406008C Composition exhibiting enhanced formulation stability and delivery of topical active ingredients
03/15/2011CA2394809C Benzazole derivatives and their use as jnk modulators
03/15/2011CA2381586C A glass composition
03/15/2011CA2379575C Pharmaceutically active sulfonamide derivatives
03/15/2011CA2376326C Unfermented gel fraction from psyllium seed husks
03/15/2011CA2373653C New use of compounds as antibacterial agents
03/15/2011CA2277192C Nuclear transfer with differentiated fetal and adult donor cells
03/15/2011CA2232191C Inhibition of tumor necrosis factor alpha
03/10/2011WO2011029102A2 Cd117+cells and uses thereof
03/10/2011WO2011028935A2 Methods of treating mitochondrial disorders using metalloporhyrins
03/10/2011WO2011027893A1 Method for prediction of therapeutic effect on chronic hepatitis c
03/10/2011WO2011027888A1 Diamide-phenyl derivative and pharmaceutically acceptable salt thereof
03/10/2011WO2011027875A1 Agent for improving intestinal tract barrier function
03/10/2011WO2011027829A1 Composition containing rna derived from lactic acid bacterium as active ingredient
03/10/2011WO2011027807A1 Immunity inducer
03/10/2011WO2011027551A1 Hydrogen sulfide-producing enzyme inhibitor
03/10/2011WO2011027046A1 Use of secnidazole in combination with an active antibiotic against aerobic bacteria for treating diverticulitis
03/10/2011WO2010117756A3 Substituted benzimidazole pharmaceutical formulations
03/10/2011WO2009130735A8 Fatty acid derivatives for oral administration endowed with high palatability
03/10/2011US20110060130 Neutralizing human anti-igfr antibody
03/10/2011US20110060046 Agent and food for preventing/improving functional digestive disorder
03/10/2011US20110060026 Indoles Active on CRTH2 Receptor
03/10/2011US20110060017 Novel 1,2,3-triazole derivatives useful as modulators of nicotinic acetylcholine receptors
03/10/2011US20110060012 4-[3-(aryloxy)benzylidene]-3-methyl piperidine 5-membered aryl carboxamide compounds useful as faah inhibitors
03/10/2011US20110060010 Salts of 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)piperidine-2,6-dione and derivatives thereof, or polymorphs of salts, process for preparing same and use thereof
03/10/2011US20110060007 Novel NIP Thiazole Derivatives as Inhibitors of 11-Beta-Hydroxysteroid Dehydroge-Nase-1
03/10/2011US20110060006 Functionally Selective Alpha2C Adrenoreceptor Agonists
03/10/2011US20110060002 Conglomerates of tenatoprazole potassium salts
03/10/2011US20110059999 Hydroxymethylcyclohexylamines
03/10/2011US20110059995 Substituted xanthine derivatives
03/10/2011US20110059984 Heterocycles useful as modulators of ion channels
03/10/2011US20110059976 Pyrido pyrimidinones, dihydro pyrimido pyrimidinones and pteridinones useful as raf kinase inhibitors
03/10/2011US20110059966 Indole derivatives as histamine 3 receptor inhibitors for the treatment of cognitive and sleep disorders, obesity and other cns disorders
03/10/2011US20110059957 Benzene or thiophene derivative and use thereof as vap-1 inhibitor
03/10/2011US20110059955 Novel 3-aminoalkyl-1,3-dihydro-2h-indol-2-one derivatives, preparation thereof and therapeutic use thereof